These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34327853)

  • 41. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
    Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
    ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ivabradine effects in hospitalized acute heart failure patients: a single center retrospective study.
    Abdelnabi M; Benjanuwattra J; Saleh Y; Badran H; Ahmed S; Almaghraby A
    Am J Cardiovasc Dis; 2023; 13(3):177-182. PubMed ID: 37469535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
    Lan WR; Lin SI; Liao FC; Chang HY; Tsai CT; Wu YJ; Liu PY; Chen CH; Lee YH
    Am J Cardiol; 2021 Jul; 150():77-81. PubMed ID: 34006371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic impact of mineralocorticoid receptor antagonist in patients with heart failure with preserved ejection fraction.
    Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
    ESC Heart Fail; 2020 Oct; 7(5):2752-2761. PubMed ID: 32592265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy.
    Cho MS; Kim MS; Lee SE; Choi HI; Lee JB; Cho HJ; Lee HY; Choi JO; Jeon ES; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Ahn Y; Kim KH; Park HY; Cho MC; Oh BH; Kim JJ
    Can J Cardiol; 2018 Sep; 34(9):1145-1152. PubMed ID: 30170669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings.
    Mazza A; Townsend DM; Torin G; Schiavon L; Camerotto A; Rigatelli G; Cuppini S; Minuz P; Rubello D
    Biomed Pharmacother; 2020 Oct; 130():110596. PubMed ID: 34321170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin therapy and mortality among patients hospitalized with heart failure and preserved left ventricular function--a preliminary report.
    Roik M; Starczewska MH; Huczek Z; Kochanowski J; Opolski G
    Acta Cardiol; 2008 Dec; 63(6):683-92. PubMed ID: 19157162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization.
    Faragli A; Tano GD; Carlini C; Nassiacos D; Gori M; Confortola G; Lo Muzio FP; Rapis K; Abawi D; Post H; Kelle S; Pieske B; Alogna A; Campana C
    Front Cardiovasc Med; 2021; 8():665202. PubMed ID: 34395550
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of ivabradine on numbers needed to treat for the prevention of recurrent hospitalizations in heart failure patients.
    Rogers JK; Kielhorn A; Borer JS; Ford I; Pocock SJ
    Curr Med Res Opin; 2015; 31(10):1903-9. PubMed ID: 26361063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
    Lyu S; Yu L; Tan H; Liu S; Liu X; Guo X; Zhu J
    BMC Cardiovasc Disord; 2019 Sep; 19(1):209. PubMed ID: 31477021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ivabradine on left ventricular diastolic function of patients with heart failure with preserved ejection fraction -IVA-PEF study.
    Tanaka H; Yamauchi Y; Imanishi J; Hatani Y; Hayashi T; Hirata KI
    J Cardiol; 2021 Jun; 77(6):641-644. PubMed ID: 33390289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ivabradine, a novel medication for treatment of heart failure with reduced ejection fraction.
    Foster JL; Bobadilla RV
    J Am Assoc Nurse Pract; 2016 Nov; 28(11):576-582. PubMed ID: 27215699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Importance of Heart Rate in Heart Failure and Reduced Ejection Fraction.
    Prasun MA; Albert NM
    J Cardiovasc Nurs; 2018; 33(5):453-459. PubMed ID: 29621054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.